As director of strategy for QualityOne, Sophia Finn is the QualityOne team’s resident quality subject matter expert. She brings to the team over 10 years of direct quality experience in regulated industries.
She began her career with the FDA working in CBER’s vaccine lot release program and later moved to the FDA’s office of regulatory affairs as a regulatory microbiologist. Additionally, Sophia has managed CAPA, complaints, audit, and deviation programs in the medical device industry.
Sophia has a master of science in bioscience in regulatory affairs from Johns Hopkins University and is an ASQ Certified Quality Auditor.